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We describe a practical, technically convenient DEAESephadex chromatographic column and a three-fraction salt-gradient elution procedure, with which serum creatine kinase activity is rapidly and quantitatively separated into the isoenzyme components with excellent analytical recovery of the total activity applied. The homogeneity of the isoenzyme fractions was demonstrated by electrophoresis and rechromatography. Sera assessed by the Mercer fractionation [C/in. Chem. 20, 36 (1974) ] and the present procedure showed excellent agreement.
Three tissue creatine kinase (ATP:creatine

N-
phosphotransferase, EC 2.7.3.2) isoenzymes-MM, from skeletal muscle, MB, principally from myocardial tissue, and BB from brain tissue-have been identified (1). Among healthy humans, the serum contains the MM isoenzyme almost exclusively, MB and BB isoenzymes are insignificant or absent. A myocardial infarct is followed within a few hours by a diagnostically significant increase in the patient's serum MB isoenzyme fraction. Demonstrated initially by electrophoresis, for example ref. 2 , these techniques are laborious and are limited in sensitivity to about 10 U of MB isoenzyme per liter (3) . Mercer (4) , reported that serum CK' isoenzymes could be separated without prior treatment by a 10-fraction-and a year later (5) , with better instrumental sensitivity, by a 12-fraction-stepwise gradient elution on a column containing DEAE-Sephadex.
The data for MB isoenzyme obtained by this technique and its excellent clinical diagnostic correlation with patients suffering myocardial infarctions have been generally confirmed by other investigators using either the same or modified chromatographic procedures (6) (7) (8) (9) three-fraction salt-gradient-elution procedure that rapidly and quantitatively separates serum total CK activity into the individual isoenzymes with excellent recovery of the total enzyme applied.
Materials and Methods
The Anion-Exchange Chromatographic Column
The assembled column is an 8 X 150 mm glass tube fitted with a plastic tip containing a porous filter disk. The tube is filled to a bed height of about 5 cm with DEAE-Sephadex A-SO (Pharmacia, Piscataway, N.J. 08854) prepared as described by Mercer (4). 
Eluting Buffers
Serum CK lsoenzyme Preparation
Initially, in isoenzyme separation experiments we used buffered extracts of homogenized human myocardial tissue (10) . The extracts were diluted with normal human serum to give preparations with a total CK activity of about 1000 U/liter (30 #{176}C). Later, equally good preparations were made simply by extracting acetone-powdered heart tissue with normal human serum. After centrifugation (40 000 X g, 4 #{176}C, 10 mm) mercaptoethanol or dithiothreitol (Calbiochem, La Jolla, Calif. 92037) was added to the supernatant fluid to give an estimated concentration of 2 mmol/liter. The preparations were adjusted to an approximate total CK activity of 1000 U/liter (30 #{176}C). Aliquots of 1.5 ml were dispensed into vials, capped, and kept frozen. These serum preparations were stable for several months. The fluid above the gel in the column was allowed to drain and the effluent was discarded. One milliliter of serum was layered on-the gel bed, allowed to enter the gel, and the effluent collected in a tube marked "MM." Two 4-ml portions of the MM isoenzyme buffer were added and the effluent was collected in the same tube. The tube was replaced by one marked "MB." Two 4-ml portions of the MB isoenzyme buffer were added and the entire effluent was collected in the MB tube. If the BB isoenzyme was sought, the MB tube was then replaced by one marked "BB" and two 4-ml portions of the BB isoenzyme buffer were added and the entire effluent was collected therein.
Enzyme assay. In the work presented here, specimens were assayed (11) 
Enzyme activity, U/liter, was calculated from the well-known formula relating iA/min to the reduction of 1 jzmol of NAD per minute and the molar absorptivity of the NADH produced (11) . In the present assay, the calculated factors are:
Total serum CK activity (U/liter): A/min X 4180
MM isoenzyme (U/liter): A/min X 4180 X 9 (ml eluate) = A/min X 37620
MB or BB isoenzyme (U/liter): A/min X 563 X 8 (ml eluate) = A/min X 4504
To calculate the percentage isoenzyme for each fraction:
(U of CK (isoenzyme) per liter/U of CK (total) per liter) X 100 = % isoenzyme fraction
Results
Isoenzyme Chromatography Figure 1 shows a typical elution pattern obtained when normal serum containing human myocardial tissue extract (412 total CK U/liter) was chromatographed as described, 1.0-ml fractions were collected, and aliquots were assayed. A total of 425 CK U/liter (102.6%) was recovered and was distributed into 351 U of MM per liter (82.6%), 71 U of MB per liter (16.7%), and 3 U of BB per liter (0.7%). It will be seen that tube 9, the last MM fraction, and tube 17, the last MB fraction, each assayed at 3 U/liter, indicating excellent separation.
The residual fluids in the individual MM and MB fractions were pooled, each isoenzyme pool was concentrated separately on an Amicon B15 micro concentrator (Amicon Corp., Lexington, Mass. 02173) and the concentrates were rechromatographed on separate columns, 1.0-ml fractions being collected. Figure 2 shows that excellent separation has been achieved with no apparent "tailing" or "carryover."
In another experiment, 1.0 ml of a serum preparation containing human myocardial tissue extract (1187 total CK U/liter) was fractionated by the three-fraction procedure and gave the isoenzyme composition of 1114 U of MM per liter (91.6%), 91 U of MB per liter (7.5%), and 11 U of BB per liter (0.9%). The remaining eluate of each fraction was concentrated 50-fold and 3-zl aliquots of each concentrate were electrophoresed on agarose. Figure 3 , which shows the stained pattern, indicates that the eluted isoenzyme fractions are homogeneous, with no carryover of the preceding or retention of the following isoenzyme fraction. Furthermore, when the concentrated fractionswere each rediluted to 1.0 ml in NaC1 (8.5 g/liter) and each fraction was placed on a Serum with a total CK activity of 1023 U/liter from another patient with a myocardial infarct was fractionated into, per liter, 835 U of MM (81.6%), 99 U of MB (9.7%), and 3 U of BB (0.3%). Each eluate fraction was concentrated 50-fold, the individual concentrates were removed, each concentration compartment was rinsed twice with 200 l of saline, the washings were added to the respective concentrates, and each fraction was diluted to 1.0 ml and applied to a separate column and rechromatographed to give the results shown in Table 2 . Excellent separation is seen once more.
Evaluation of Roche Column Performance
separate column and rechromatographed, the separation was excellent (Table 1) .
Serum from a patient with a myocardial infarct was similarly examined. The serum serum contained, per liter, 639 U of MM (91.8%), 53 U of MB (8.3%), and 4 U of BB (0.6%). The fractions were concentrated and aliquota were electrophoresed, gaving the pattern shown in Figure 4 . The electrophoresis shows a separation into homogeneous component isoenzymes. The remainder of the concentrated fractions were rediluted to 1.0 ml
The range of isoenzyme composition capable of being resolved by the columns was determined by applying 2.0-, 1.0-, 0.50-, 0.25-, and 0.1-ml aliquots of a serum containing 883 U of CK per liter to individual columns and eluting the isoenzymes as described. The results are summarized in Table 3 . Thus, over a 20-fold range of enzyme activity, the mean MM isoenzyme content was 87.2% (range: 84.1-92.2%); the mean MB isoenzyme content was 11.6% (range: 7.8-14.3%), and the meanBB content was 0.94% (range: 0-2.1%). Analytical recovery Figure 5 shows the linear relationship between the actually measured actmvities of the two eluted isoenzyme fractions with the volume of serum applied to the columns. Thus it is clear that the column can easily and quantitatively resolve 100 to 1800 U of CK per liter in serum into its component isoenzymes, but is not restricted to these limits.
Precision and Reproducibility
The precision of the Roche column performance was determined by adding 1.0-nil aliquots of a normal serum with an activity of 41 U/liter to 10 columns and isolating the isoenzymes by the described procedure. The MM fractions had a mean (±SD)activity of 41 ±2.1 U/liter (CV = 5.3%); the MB fractions had activities ranging from 0-0.8 U/liter. The mean analytical recovery was 99% (range: 95,1-104.8%).
The isoenzymes in 1.0-ml aliquots of a serum with a total CK assay of 875 U/liter were similarly fractionated on 14 columns. The MM fractions had a mean activity of 782 ± 38 U/liter (CV = 4.8%); the MB fractions had a mean activity of 104 ± 6.9 U/liter (CV = 6.6%). Analytical recovery of the total enzyme was 101.3% (range: 96.9-108%).
Day-to-day performance of the Roche columns was also evaluated by fractionating 1.0 ml and 0.5 ml of the same serum daily over a 19-working-day interval, and 0.25 ml daily for six days. The coefficients of variation for the MM and the MB isoenzymes are: 1.0 ml, 6.7 and 6.5%, respectively; 0.5 ml, 5.6 and 11.8%; 0.25 ml, 8.1 and 18.6%. The mean recovery of the enzyme activity applied was 98% (range: 92.3-102.4%).
The precision of the enzyme assay was determined by fractionating:
(a) serum from a subject in apparent good health, (b) serum from a patient with a clinically documented myocardial infarct, and (c) our reference serum preparation. The MM and MB effluents (and the BB effluent from a reference serum preparation) from several columns were pooled to provide sufficient sample and each pool was analyzed 10 times. The following results were obtained: (mean ± 1 SD; CV (%)): (a) MM, 61 ± 1.6, 2.6; MB, 0-1.5; (b) MM, 86.7 ± 1.87, 2.2; MB, 12.7 ± 1.3, 10.2; (c) MM, 928 ± 67, 7.2; MB, 17 ± 4.7, 4.0; BB, 5 ± 0.6, 12.0.
Comparison with the Mercer Procedure
The Mercer 12-fraction procedure and the Roche three-fraction procedure were compared by applying 1-ml samples of undiluted serum with an activity of 950 total CK units and 1.O-ml volumes of saline dilutions of the same serum corresponding to 0.5,0.25, and 0.125 ml of serum to a Pasteur-pipette column prepared according to Mercer's directions (4) and to the Roche column. The isoenzymes were eluted as described by Mercer for the pipette column and by the present procedure for the Roche columns. The results obtained are summarized in Table 4 . There is excellent agreement between the two systems when the mean activities of each isoenzyme fraction are compared. These means are well within 1 SD of the means calculated for all assays combined. For the 12-fraction procedure, the mean analytical recovery was 96.4% (range: 92.3-1045%); for the Roche three-fraction procedure the mean recovery was 93.7% (range: 88.8-99.6%).
Reference Values
The results of chromatographic CK isoenzyme assays of sera from 104 asymptomatic adult subjects, of both sexes and with no history of cardiac disease, are shown 
Discussion
The aims of this study were to simplify the chromatographic CK isoenzyme fractionation procedure described by Mercer (4, 5) with: (a) a DEAE-Sephadexcontaining column which could be prepared on a commercial scale with sufficient head-space for addition of larger volumes of liquid; (b) a simpler elution scheme with fewer fractions; (c) consistent and reproducible isoenzyme separation with no or insignificant tailing between fractions; (d) an assay procedure not requiring concentration of the isoenzyme eluates; and (e) quantitative analytical recovery of the total enzyme applied to the column.
A commercial chromatographic CK isoenzyme procedure (12) has been evaluated and important deficiencies have been reported (13, 14) , resulting in a reformulation of the MB eluting buffer (15) to one more closely resembling the one used by Mercer.
The Chromatographic Column
The characteristics of our column very closely reproduced those of the pipette column used by Mercer in three important ways: performance, total capacity, and reproducibility.
First, we determined the volumes, in 1.0-mi additions of each buffered salt solution, required to quantitatively elute the CK isoenzymes of a myocardium extract in a serum matrix. A total of 8 ml each of the MM and the MB buffer was required. Only traces of enzyme were found in the BB eluate, as expected. Repeating the experiment and eluting the isoenzymes with two 4-ml additions of each buffered salt solutions but collecting the eluate in 1.0-ml fractions afforded an almost identical pattern (Figure 1 ). We also measured the protein content of the eluate fractions to determine whether any nonspecific serum protein binding to the anion-exchange gel had occurred, thereby interfering with the isoenzyme separation. The protein elution profile paralleled the enzyme elution profile, indicating no interference.
Rechromatography of the concentrated isoenzyme eluates showed a very high degree of homogeneity in each isoenzyme fraction. When sera from patients suffering myocardial infarcts were chromatographed by the three-fraction procedure and the isoenzyme fractions were examined by both electrophoresis and rechromatography, excellent separation was also found. By actual measurement, the column-gel bed configuration was able to readily resolve the isoenzymes in a serum with a total CK activity of almost 1800 U/liter (30 #{176}C). This may not be the upper limit but was a useful index of the column performance.
In the event that a serum specimen is encountered with much greater CK activity, less sample need be chromatographed. Considerable flexibility is thereby possible.
Equally important is the ability of the column to separate the isoenzymes when the total serum CK activity is in the clinically normal range or slightly above normal but contains abnormal amounts of MB isoenzyme, as reported recently by Mercer and Varat and others (5, 16, 17) . We were able to examine a serum of this kind (see precision experiment above) although the time during the patient's clinical course when this specimen had been obtained was not given. Nevertheless, the Roche column and procedure readily separated and quantified the isoenzymes. Undoubtedly, as more clinical experience is correlated with the results of the chromatographic technique, clinical entities other than myocardial infarction will be identified, for example ref.
18, when increased amounts of MB are present in the serum. During our study no patients were found similar to those reported by Clejan et al. (18) or Velletri et al.
(19).
In the present studies, three technical elements were noteworthy. First was the good agreement among the percentages of the isoenzyme composition over an almost 20-fold range of total CK activity (Table 3) . Second was the linear relationship between the chromatographically isolated isoenzymes activities and the amount of serum applied to the column ( Figure 5 ). Third was the excellent mean recovery of the total CK activity applied to the column: 99.1% (range: 92.7-104%).
The lsoenzyme Eluates
The column dimension and gel bed configuration allowed complete absorption of the isoenzyme proteins and their rapid but selective elution with successive alterations in the anionic environment. The initial eluting buffer drained at a mean rate of 0.5 mi/mm. As the eluting buffer salt content increased, the gel bed contracted and, even though the flow rate increased slightly, the isoenzymes were quantitatively separated rapidly.
The total volumes of the isoenzyme effluents collected were less than 5% greater than the actual volumes of buffers applied to the column. The difference in assay results obtained when the applied volumes-e.g., 9.0 ml (MM fraction) and 8.0 ml (MB or BB)-or when the actually measured effluent volumes were used in the calculation of isoenzyme activities did not exceed 1.0%.
The experimental literature describing serum CK assays contains conflicting reports regarding the effect of specimen dilution on the results of the assay (see 20 and references cited therein). Nealon and Henderson (7) had reported that serial dilution of the specimen did not affect the isoenzyme distribution when separated on a DEAB-cellulose column. The column eluates in the present procedure represent, at least, an eight-fold dilution of the serum and its isoenzyme components and it was of interest, therefore, to determine any effect of such dilution. Assays of total CK activity of an undiluted serum specimen (activity: 1000 U/liter) and of 0.1-mi aliquots of the same serum that had been serially diluted 32-fold with saline, after normalizing the results, gave a mean activity of 994 ± 39.8 U/liter (CV = 4.0%). Resolution of Roche columns and assay of the isoenzymes in another undiluted serum and three salinediluted aliquots of the same serum disclosed that the variation in the results of isoenzyme composition derived from the four specimens was within 2.1% for MM and 9.0% for MB (Table 8) . These findings were consistent with and almost identical to those reported by Nealon and Henderson (7). These data suggest: (a) that the postulated inhibitors, whose effect on the assay is presumably diminished on dilution, were not present in the specimens analyzed in the present study; (b) the nonlinearities observed by others might be related to the recognized limitations of the procedures used in the earlier studies, i.e., nonoptimum amounts of substrate, cofactors, buffer type, particular activators, etc. (21); (c) the reported dilution effect may be uniquely related to the MM isoenzyme, which is found in extraordinarily large amounts in neuromuscular diseases. Our present study did not include such cases. On the other hand, we have from time-to-time observed examples of serum isoenzyme separations where the activity of the MM fraction was greater than the separately measured total CK activity of the serum examined, resulting in recoveries in excess of 100%; this was not related to the level of total CK activity measured. This, too, has been observed by others (16) . At present, we cannot explain this.
The Enzyme Assay
Though the essence of the CK isoenzyme procedure is the resolving power of the chromatographic separation, clinical decisions will depend also on the reliability of the enzyme quantification once the isoenzymes are separated.
Numerous substrate modifications have been introduced since Rosalki proposed his kinetic assay procedure, all aimed at improving the assay by optimizing the concentrations of the components. A partial summary and evaluation of these efforts was reported by Szasz et al. (21) . Nevertheless, with substrates of differing composition, dissimilar results were obtained, even when the identical enzyme material was assayed (22, 23) .
The "optimized" substrates used in our earliest experiments contain glutathione as the sulfhydryl activator (24). This has now been shown to be inefficient (14, 21) , and we discontinued using this formulation. For our studies, we sought a substrate whose composition embodied the recent improvements in sulfhydryl activatois and sources of coupling enzymes and whose effective composition in the final reaction mixture could be varied by adjusting the volume of reconstituting fluid, thus attaining maximum sensitivity at low levels of enzyme activity. The substrate formulation detailed in the experimental section fulfilled these requirements.
Addition of aliquots of the isoenzyme eluates of as much as 1.0 to 2.5 ml to the substrate solution neither shifted the pH to a nonoptimum value nor did the resulting mixture contain inhibiting amounts of Cl-(21). Had inhibiting amounts of Cl-been present, we would not have attained the linearity found between the activity of the eluted isoenzyme fractions and the volume of serum applied to the columns ( Figure 5 ). Again, we sought maximum sensitivity, particularly at low levels of MB activity, without concentrating the eluate. Concentrating the eluates resulted in poor analytical recovery of the activity. With our spectrophotometer we could measure the equivalent of 0.8 U of MM and 0.9 U MB or BB per liter, either via the digital readout or, graphically, with the 0.1 A full-scale setting.
The duration of the lag phase with the present substrate as determined by inspection of recordings did not exceed 2 mm at levels between 30-1000 U/liter. However, to ensure readings in the kinetically linear range, for total CK and the MM isoenzyme measurements, we waited at least 3 mm before taking an initial absorbance reading and 5 mm for MB and BB isoenzyme assays. Measuring absorbances at 1-mm intervals after the lag period, as well as inspecting the simultaneous recordings, disclosed that kinetic linearity extended for at least 10 mm beyond the initial reading, even at 1000 U/liter. We are confident that the two-point readings are kinetically reliable.
Human serum total CK activity does not follow a gaussian distribution (25,26) ; hence we present only the mean and the range of assay results from the series we studied. Serum from one man with a total CK activity of 34 U/liter had a MB isoenzyme content of 5.4 U/liter. A repeated analysis gave almost identical results. We could not obtain another specimen from that individual, because the coded specimens were received identified only by age and sex. Serum from one women with a total CK activity of 296 U/liter had a MB isoenzyme content of 4.5 U/liter. The MB fraction in this case is 1.5% of the total and is not considered significant for myocardial injury by the Mercer-Varat criteria.
